Abstract:Polymeric materials have been used in a range of pharmaceutical and biotechnology products for more than 40 years. These materials have evolved from their earlier use as biodegradable products such as resorbable sutures, orthopaedic implants, macroscale and microscale drug delivery systems such as microparticles and wafers used as controlled drug release depots, to multifunctional nanoparticles (NPs) capable of targeting, and controlled release of therapeutic and diagnostic agents. These newer generations of targeted and controlled release polymeric NPs are now engineered to navigate the complex in vivo environment, and incorporate functionalities for achieving target specificity, control of drug concentration and exposure kinetics at the tissue, cell, and subcellular levels. Indeed this optimization of drug pharmacology as aided by careful design of multifunctional NPs can lead to improved drug safety and efficacy, and may be complimentary to drug enhancements that are traditionally achieved by medicinal chemistry. In this regard, polymeric NPs have the potential to result in a highly differentiated new class of therapeutics, distinct from the original active drugs used in their composition, and distinct from first generation NPs that largely facilitated drug formulation. A greater flexibility in the design of drug molecules themselves may also be facilitated following their incorporation into NPs, as drug properties (solubility, metabolism, plasma binding, biodistribution, target tissue accumulation) will no longer be constrained to the same extent by drug chemical composition, but also become in-part the function of the physicochemical properties of the NP. The combination of optimally designed drugs with optimally engineered polymeric NPs opens up the possibility of improved clinical outcomes that may not be achievable with the administration of drugs in their conventional form. In this critical review, we aim to provide insights into the design and development of targeted polymeric NPs and to highlight the challenges associated with the engineering of this novel class of therapeutics, including considerations of NP design optimization, development and biophysicochemical properties. Additionally, we highlight some recent examples from the literature, which demonstrate current trends and novel concepts in both the design and utility of targeted polymeric NPs (444 references).

[Development of Polymeric Nanoparticles in the Targeting Drugs Carriers].

A Review on Polymer and Lipid-Based Nanocarriers and Its Application to Nano-Pharmaceutical and Food-Based Systems

Recent Advances in Polymeric Nano-sized Carrier Systems

Polymer-drug and polymer-protein conjugated nanocarriers: Design, drug delivery, imaging, therapy, and clinical applications.

Research Progress of Nanoparticle Carriers and Their Biological Effects

Polymeric nanoparticles-Promising carriers for cancer therapy

Targeted Polymeric Therapeutic Nanoparticles: Design, Development and Clinical Translation

Multifunctional biodegradable polymeric nanocarriers: Design, synthesis, and applications in targeted tumor therapy

Polymeric Nanoparticles for a Drug Delivery System.

Polymeric Micelles: Nanocarriers for Cancer-Targeted Drug Delivery

Polymeric Micelles As Nanocarriers for Drug Delivery

Advanced Engineered Nanoparticulate Platforms to Address Key Biological Barriers for Delivering Chemotherapeutic Agents to Target Sites.

Polymeric Micelles and Targeting Drug Delivery Systems for Cancer Therapy

Rational design of polymeric micelles for targeted therapeutic delivery

Modification Of Nano-Sized Materials For Drug Delivery

Enhancing the Therapeutic Efficacy of Nanoparticles for Cancer Treatment Using Versatile Targeted Strategies

Nanoparticles for tumor targeted therapies and their pharmacokinetics.

Advances in Targeted Drug Delivery System

Polymer Nanoparticles for Drug Delivery System

Applications of Polymeric Nanocapsules in Field of Drug Delivery Systems.

Polymer Nanoparticles for the Delivery of Drug and Gene